Surgical treatment of liver metastases

Seminars in Oncology

Volumn 29, Issue 2, 2002, Pages 107-118

  Sasson, Aaron R ^a,b   Sigurdson, Elin R ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE ASSOCIATION; HUMAN; INTRAOPERATIVE PERIOD; LIVER METASTASIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS;

EID: 0036220808     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2002.31676     Document Type: Article

References (82)

1. Cancer statistics, 2001
2. The National Cancer Data Base. Report on colon cancer
3. Hepatic resection for metastases from colorectal carcinoma is of dubious value
4. Haematogenous metastatic patterns in colonic carcinoma: An analysis of 1541 necropsies
5. A retrospective study of the natural history of patients with liver metastases from colorectal cancer
6. Factors influencing survival in patients with untreated hepatic metastases
7. The natural history of primary and secondary malignant tumors of the liver. 1. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy
8. Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history
9. Resection of hepatic metastases from colorectal cancer
10. Surgical treatment of hepatic metastases from colorectal cancers
11. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence
12. Resection of colorectal liver metastases
13. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients
14. Hepatic resection for metastatic colorectal cancer results in cure for some patients
15. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
16. Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors
17. Ninety-six five-year survivors after liver resection for metastatic colorectal cancer
18. Liver resection for colorectal metastases
19. Patterns of recurrence after resection of colorectal liver metastases: Prediction by models of outcome analysis
20. Hepatic resection for metastatic colorectal adenocarcinoma: A proposal of a prognostic scoring system
21. One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants
22. Surgical margin in hepatic resection for colorectal metastasis: A critical and improvable determinant of outcome
23. Patient selection for hepatic resection of colorectal metastases
24. Registry of Hepatic Metastases: Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of indications for resection
25. An orthotopic mouse model of remetastasis of human colon cancer liver metastasis
26. Lymphatic dissemination of hepatic metastases. Implications for the follow-up and treatment of patients with colorectal cancer
27. Resection of both hepatic and pulmonary metastases in patients with colorectal carcinoma
28. Surgical treatment of hepatic and pulmonary metastases from colon cancer
29. Is resection of pulmonary and hepatic metastases warranted in patients with colorectal cancer?
30. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group protocol 6584
31. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
32. Survival after resection of multiple hepatic colorectal metastases
33. Initial presentation with stage IV colorectal cancer: How aggressive should we be?
34. Role of chest CT in patients with negative chest x-rays referred for hepatic colorectal metastases
35. Metachronous colorectal cancers
36. Detection of recurrent and metastatic colorectal cancer: Comparison of positron emission tomography and computed tomography
37. Contribution of PET in the diagnosis of recurrent colorectal cancer: Comparison with conventional imaging
38. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer
39. Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: The utility of positron emission tomography (PET)
40. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer
41. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver
42. 18F]fluorode-oxyglucose in identifying operable colorectal cancer metastases to the liver
43. CT and MR imaging of hepatic metastases
44. Comparison of CT, MRI and CT during arterial portography in the detection of malignant hepatic lesions
45. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: Sensitivity based on comparison with intraoperative and pathologic findings
46. The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth
47. Hepatic tumors: Comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation
48. Hepatic metastases from colorectal cancer: Detection and false-positive findings with helical CT during arterial portography
49. False-positive CT portography: Correlation with pathologic findings
50. Detection of hepatic metastases: Ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography
51. Terminology of liver anatomy and liver resections: Coming to grips with hepatic Babel
52. Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound
53. Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography
54. Role of staging laparoscopy in the treatment of hepatic malignancy
55. A prospective analysis of staging laparoscopy in patients with primary and secondary hepatobiliary malignancies
56. A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases
57. Intraoperative ultrasound in the management of liver neoplasms
58. Intraoperative ultrasonographic detection of occult liver metastases in colorectal cancer
59. Is CT portography (CTAP) really useful in patients with liver tumors who undergo intraoperative ultrasonography (IOUS)?
60. Impact of intraoperative ultrasonography on surgical treatment of liver tumours
61. Laparoscopic ultrasound vs triphasic computed tomography for detecting liver tumors
62. Improved staging of liver tumors using laparoscopic intraoperative ultrasound
63. Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma
64. Nonanatomic hepatic resection for secondary hepatic tumors with special reference to hemostatic technique
65. Resection of liver metastases - When is it worthwhile?
66. Liver resection for colorectal metastases
67. Morbidity and mortality after hepatic resection of metastases from colorectal cancer
68. Resection of 'recurrent' colorectal metastases to the liver
69. Repeat hepatic resections for metastatic colorectal cancer
70. Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 Cases
71. Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry
72. Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases
73. Repeat hepatectomy for colorectal liver metastases
74. Repeat liver resection for recurrent colorectal liver metastases
75. Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma
76. Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors
77. Neo-adjuvant therapy improves resectability rates for colorectal liver metastases
78. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
79. Relevance of neoadjuvant and adjuvant treatment for patients with resectable liver metastases of colorectal carcinoma
80. Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases
81. Retrospective study on adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver